Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.6B | 9.5B | 9.6B | 8.9B |
Cost of revenue | 1.9B | 2.0B | 1.8B | 1.8B |
Gross profit | 7.7B | 7.5B | 7.8B | 7.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 973M | 930M | 1.2B | 912M |
Other operating expenses | — | — | — | — |
Operating income | 6.4B | 6.3B | 6.4B | 6.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 158M | 182M | 176M | 196M |
Other income expense | -839M | 104M | 189M | 234M |
Pretax income | 5.4B | 6.2B | 6.4B | 6.0B |
Tax provision | 861M | 1.1B | 1.1B | 1.1B |
Net income | 4.6B | 5.1B | 5.3B | 4.9B |
Basic EPS | — | 2.6 | 2.7 | 2.4 |
Diluted EPS | — | 2.6 | 2.7 | 2.4 |
Basic average shares | — | 1.5M | 1.4M | 1.4M |
Diluted average shares | — | 1.7M | 1.7M | 1.7M |
EBITDA | 6.7B | 6.6B | 6.6B | 6.2B |
Net income from continuing op. | 4.6B | 5.1B | 5.3B | 4.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |